More Information about Oleander

[Guest guest]

Many in this group may not have read my book or some of the files here

on this site, and so may still wonder about the use of oleander, a

highly toxic plant in raw form, but something many of us view as quite

wondrous when properly boiled and strained - as it is in the home

remedy " oleander soup " , the patented medicine Anvirzel TM and the

rainforest supplement OPC.

 

For further enlightenment, I offer an excerpt on oleander in the

directions and information that accompanies the oleander based

rainforest supplement known as OPC which has been used in South Africa

with tremendous success in reversing HIV and beat cancer. I am not

selling the product (although I whole heartedly endorse it) and I

promote it only because of it's ability to save lives, but it is

available commercially at one internet site and privately at a

considerably lesser price directly from the patent holder in South Africa.

 

This information mirrors what I have found about oleander in my

research and what I have written about oleander. Note: oleander is but

one of four rainforest botanicals used in OPC, but does make up 80% of

the supplement. The other three are the agaricus blazei murill

mushroom, cat's claw and pau d'arco.

 

Nerium Oleander

 

An aqueous extract of Nerium Oleander has been patented

internationally as ANVIRZEL TM. (US Patent #5,135,745) The Nerium

Oleander extract used in the Agaricus OPC proprietary herbal mix is

similar to the ANVIRZEL TM extract and the following excerpt is taken

from the description of ANVIRZEL TM on the Internet:

 

Extensive laboratory and clinical experience indicate both cytotoxic

and immunological activities for the drug. In developing a protocol

for clinical trials, M.D. Anderson Cancer Center states, " It is

thought that the polysaccharides present in ANVIRZELTM are capable of

activating the immune cells, which in turn can recognize the epitopes

present on the cancer cell surfaces, thereby enhancing the efficacy of

the immune response. It is believed that the cytotoxic action present

in the extract may be essential for synergistic activities. It is

believed that the cytotoxic action both arrests tumor growth and

prevents cancer cell reproduction as well as having and/or producing a

Tumor Necrosis Factorlike activity. Research has proved conclusively

that AnvirzelTM is active on dual pathways at the cellular level to

both inhibit the growth of tumor cells (through the antiangiogenesis

activity of the oleandrin) and to promote apoptosis of the tumor cells.

 

Extensive in vitro research has been conducted by Dr. Robert Newman,

Chief of Pharmacology, M.D. Anderson Cancer Center (MDACC), Houston,

Texas. Dr. Newman has tested ANVIRZELTM. against a broad spectrum of

human malignant cell lines, and has demonstrated that ANVIRZELTM has a

high order of efficacy.

 

In addition to the research being conducted by M.D. Anderson Cancer

Center, concurrent research is being conducted by Dr. Wendell Winters,

a noted immunologist with the University of Texas Health Science

Center in San Antonio,Texas. Dr. Winter's work has confirmed that

ANVIRZELTM has been " shown to stimulate the immune system by

stimulation of the function and capability of specific subsets of

mononuclear cells. " In addition, Dr. Winters' research has shown that

ANVIRZELTM specifically stimulates T and B lymphocytes, the

cell-mediated and the humoral mediated immune systems.

 

In April 2000, a USFDA approved study entitled " Phase I Study of

ANVIRZELTM in Patients with Advanced Solid Tumors " was commenced under

the direction of Ronald Buckowski, M.D. at Cleveland Clinic in

Cleveland, Ohio.

 

Because of its strong cytotoxic effect in combination with an equally

strong immunomodulatory effect, ANVIRZELTM is indicated as a therapy,

both primary and adjuvant, for cell proliferative disease (cancer),

certain viral disease, and autoimmune/inflammatory disease. Clinical

application of ANVIRZELTM in the United States, Ireland, and Honduras

has demonstrated efficacy against various neoplastic disease, hepatic

disease such as Hepatitis C, late and early stage HIV/AIDS, as well as

autoimmune/inflammatory disease such as rheumatoid arthritis and

psoriasis. The results have been determined both by the clinical

practitioner and independent laboratory analysis using PET, CT scan,

MRI, and hematological screening.

 

International Clinical Experience Using ANVIRZELTM Therapy

International clinicians have been treating patients suffering from

the above referenced disorders on a compassionate use basis since

1997. Many of these patients were previously diagnosed as terminal.

These clinicians have experienced a very high level of success with

disease stabilization, partial remission, and complete remission,

almost always accompanied by a very marked improvement in the

patients' quality of life.

 

Dr. Anibal Villatoro of Tegucigalpa, Honduras, Former Executive of the Honduran Institute of Social Security (administrator

of the public health system) has since January of 1999 been conducting

a compassionate use trial with ANVIRZELTM for HIV (SIDA) patients in

Tegucigalpa. His early results indicate a strong level of response to

ANVIRZELTM therapy with a feeling of homeostasis (feeling of well

being) and an improved quality of life, as well as significant

improvement in their immune systems. (Reports that slipped out in late

1999 showed that Anvirzel reversed AIDS, no matter what the phase of

the disease, arthritis, psoriasis, hepatitis C, and even diabetes in

some cases. Initially, Anvirzel was thought to work only on cancers

found early, however, very positive results have been found in people

given just weeks to live. To top this all off, Anvirzel seems to be

the first cancer remedy to show positive results for leiomyosarcoma,

probably the deadliest of cancers. Anvirzel also crosses the

blood-brain barrier (like Poly-MVA) and gives hope to people with

brain tumors.)

 

The " Common Thread " running through almost all of the clinical records

of the patient population using ANVIRZELTM on a compassionate use

basis has been the marked improvement in the " quality of life " of

those patients. This includes, but is not limited to, homeostasis,

marked improvement in pain management with elimination of or marked

reduction in use of analgesics, positive response to antibiotics,

increased appetite with concomitant weight gain, and increase in

energy with reduction of fatigue.

 

Toxicity studies. A toxicity study was performed by Southern Research

Institute, Birmingham, AL, on 28 beagle dogs, and the study states,

" No clinical signs of toxicity were noted in any of the dogs in this

study... " Another lethality assessment of ANVIRZELTM in a murine

(laboratory mouse) population was conducted by Southwest Research

Institute, San Antonio, TX., and the study states, " On the day of NOI

(Nerium Oleander Extract Injectible) administration and over a

subsequent 14 day post dose period, none of the treated animals showed

any pathological signs or ill effect of the injections as assessed by

daily morbidity and mortality observations. "

 

No reports of toxicity have been received from clinicians supervising

patients experiencing AnvirzelTM therapy.

 

Live long, live healthy, live happy!

 

Tony Isaacs

http://health.oleander soup